5-[4-[[1-[4-[4-amino-3-[4-(2-fluoro-3-methoxyphenoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexanecarbonyl]azetidin-3-yl]methyl]piperazin-1-yl]-N-(2,6-dioxopiperidin-3-yl)pyridine-2-carboxamide

C44H48FN11O6 — CID 170269310

IUPAC5-[4-[[1-[4-[4-amino-3-[4-(2-fluoro-3-methoxyphenoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexanecarbonyl]azetidin-3-yl]methyl]piperazin-1-yl]-N-(2,6-dioxopiperidin-3-yl)pyridine-2-carboxamide
SMILESCOc1cccc(Oc2ccc(-c3nn(C4CCC(C(=O)N5CC(CN6CCN(c7ccc(C(=O)NC8CCC(=O)NC8=O)nc7)CC6)C5)CC4)c4ncnc(N)c34)cc2)c1F
InChIInChI=1S/C44H48FN11O6/c1-61-34-3-2-4-35(38(34)45)62-31-12-7-27(8-13-31)39-37-40(46)48-25-49-41(37)56(52-39)29-9-5-28(6-10-29)44(60)55-23-26(24-55)22-53-17-19-54(20-18-53)30-11-14-32(47-21-30)42(58)50-33-15-16-36(57)51-43(33)59/h2-4,7-8,11-14,21,25-26,28-29,33H,5-6,9-10,15-20,22-24H2,1H3,(H,50,58)(H2,46,48,49)(H,51,57,59)
InChIKeyNECSZNNQVCMRCR-UHFFFAOYSA-N
MW845.94 g/mol
LogP3.96
Rot. Bonds11

About 5-[4-[[1-[4-[4-amino-3-[4-(2-fluoro-3-methoxyphenoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexanecarbonyl]azetidin-3-yl]methyl]piperazin-1-yl]-N-(2,6-dioxopiperidin-3-yl)pyridine-2-carboxamide

5-[4-[[1-[4-[4-amino-3-[4-(2-fluoro-3-methoxyphenoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexanecarbonyl]azetidin-3-yl]methyl]piperazin-1-yl]-N-(2,6-dioxopiperidin-3-yl)pyridine-2-carboxamide (PubChem CID 170269310) has the molecular formula C44H48FN11O6 and a molecular weight of 845.94 g/mol. Its IUPAC name is 5-[4-[[1-[4-[4-amino-3-[4-(2-fluoro-3-methoxyphenoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexanecarbonyl]azetidin-3-yl]methyl]piperazin-1-yl]-N-(2,6-dioxopiperidin-3-yl)pyridine-2-carboxamide.

Molecular Properties

Compound Name5-[4-[[1-[4-[4-amino-3-[4-(2-fluoro-3-methoxyphenoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexanecarbonyl]azetidin-3-yl]methyl]piperazin-1-yl]-N-(2,6-dioxopiperidin-3-yl)pyridine-2-carboxamide
PubChem CID170269310
Molecular FormulaC44H48FN11O6
Molecular Weight845.94 g/mol
Exact Mass845.38
IUPAC Name5-[4-[[1-[4-[4-amino-3-[4-(2-fluoro-3-methoxyphenoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexanecarbonyl]azetidin-3-yl]methyl]piperazin-1-yl]-N-(2,6-dioxopiperidin-3-yl)pyridine-2-carboxamide
SMILESCOc1cccc(Oc2ccc(-c3nn(C4CCC(C(=O)N5CC(CN6CCN(c7ccc(C(=O)NC8CCC(=O)NC8=O)nc7)CC6)C5)CC4)c4ncnc(N)c34)cc2)c1F
InChIInChI=1S/C44H48FN11O6/c1-61-34-3-2-4-35(38(34)45)62-31-12-7-27(8-13-31)39-37-40(46)48-25-49-41(37)56(52-39)29-9-5-28(6-10-29)44(60)55-23-26(24-55)22-53-17-19-54(20-18-53)30-11-14-32(47-21-30)42(58)50-33-15-16-36(57)51-43(33)59/h2-4,7-8,11-14,21,25-26,28-29,33H,5-6,9-10,15-20,22-24H2,1H3,(H,50,58)(H2,46,48,49)(H,51,57,59)
InChIKeyNECSZNNQVCMRCR-UHFFFAOYSA-N
XLogP3.96
TPSA203.03 Ų
H-Bond Donors3
H-Bond Acceptors14
Rotatable Bonds11
Heavy Atoms62
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500845.94
LogP ≤ 53.96
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 5-[4-[[1-[4-[4-amino-3-[4-(2-fluoro-3-methoxyphenoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexanecarbonyl]azetidin-3-yl]methyl]piperazin-1-yl]-N-(2,6-dioxopiperidin-3-yl)pyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[4-[[1-[4-[4-amino-3-[4-(2-fluoro-3-methoxyphenoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexanecarbonyl]azetidin-3-yl]methyl]piperazin-1-yl]-N-(2,6-dioxopiperidin-3-yl)pyridine-2-carboxamide?
The IUPAC name of 5-[4-[[1-[4-[4-amino-3-[4-(2-fluoro-3-methoxyphenoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexanecarbonyl]azetidin-3-yl]methyl]piperazin-1-yl]-N-(2,6-dioxopiperidin-3-yl)pyridine-2-carboxamide (CID 170269310) is 5-[4-[[1-[4-[4-amino-3-[4-(2-fluoro-3-methoxyphenoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexanecarbonyl]azetidin-3-yl]methyl]piperazin-1-yl]-N-(2,6-dioxopiperidin-3-yl)pyridine-2-carboxamide.
What is the SMILES notation for 5-[4-[[1-[4-[4-amino-3-[4-(2-fluoro-3-methoxyphenoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexanecarbonyl]azetidin-3-yl]methyl]piperazin-1-yl]-N-(2,6-dioxopiperidin-3-yl)pyridine-2-carboxamide?
The canonical SMILES for 5-[4-[[1-[4-[4-amino-3-[4-(2-fluoro-3-methoxyphenoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexanecarbonyl]azetidin-3-yl]methyl]piperazin-1-yl]-N-(2,6-dioxopiperidin-3-yl)pyridine-2-carboxamide is COc1cccc(Oc2ccc(-c3nn(C4CCC(C(=O)N5CC(CN6CCN(c7ccc(C(=O)NC8CCC(=O)NC8=O)nc7)CC6)C5)CC4)c4ncnc(N)c34)cc2)c1F.
What is the InChIKey of 5-[4-[[1-[4-[4-amino-3-[4-(2-fluoro-3-methoxyphenoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexanecarbonyl]azetidin-3-yl]methyl]piperazin-1-yl]-N-(2,6-dioxopiperidin-3-yl)pyridine-2-carboxamide?
The InChIKey is NECSZNNQVCMRCR-UHFFFAOYSA-N. The full InChI is InChI=1S/C44H48FN11O6/c1-61-34-3-2-4-35(38(34)45)62-31-12-7-27(8-13-31)39-37-40(46)48-25-49-41(37)56(52-39)29-9-5-28(6-10-29)44(60)55-23-26(24-55)22-53-17-19-54(20-18-53)30-11-14-32(47-21-30)42(58)50-33-15-16-36(57)51-43(33)59/h2-4,7-8,11-14,21,25-26,28-29,33H,5-6,9-10,15-20,22-24H2,1H3,(H,50,58)(H2,46,48,49)(H,51,57,59).
What are the key properties of 5-[4-[[1-[4-[4-amino-3-[4-(2-fluoro-3-methoxyphenoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexanecarbonyl]azetidin-3-yl]methyl]piperazin-1-yl]-N-(2,6-dioxopiperidin-3-yl)pyridine-2-carboxamide?
5-[4-[[1-[4-[4-amino-3-[4-(2-fluoro-3-methoxyphenoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexanecarbonyl]azetidin-3-yl]methyl]piperazin-1-yl]-N-(2,6-dioxopiperidin-3-yl)pyridine-2-carboxamide has a molecular weight of 845.94 g/mol, XLogP of 3.96, 11 rotatable bonds, 3 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[4-[[1-[4-[4-amino-3-[4-(2-fluoro-3-methoxyphenoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexanecarbonyl]azetidin-3-yl]methyl]piperazin-1-yl]-N-(2,6-dioxopiperidin-3-yl)pyridine-2-carboxamide is sourced from PubChem (CID 170269310), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).